Preferred Label : molnupiravir;

MeSH synonym : ((2R,3S,4R,5R)-3,4-dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4- dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate;

UNII : YA84KI1VEW;

Details


Main resources

You can consult :


https://www.cbip.be/fr/articles/4046?folia=4031
2023
false
false
false
Belgium
French
journal article
molnupiravir
europe

---
https://conseil-scientifique.public.lu/fr/publications/covid-19/molnupiravir.html
2022
false
false
false
Luxembourg
COVID-19
hydroxylamines
cytidine
molnupiravir
practice guideline
molnupiravir

---
https://www.has-sante.fr/jcms/p_3304143/fr/lagevrio-molnupiravir
https://www.has-sante.fr/jcms/p_3304251/fr/decision-n-2021-0313/dc/sem-du-9-decembre-2021-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-acces-precoce-de-la-specialite-lagevrio-molnupiravir
2021
false
false
false
France
COVID-19
treatment outcome
adult
antiviral agents
risk factors
aged
immunocompromised host
administration, oral
molnupiravir
evaluation of the transparency committee
molnupiravir

---
https://ansm.sante.fr/tableau-atu-rtu/lagevrio-200-mg-gelules
2021
false
false
false
France
French
COVID-19
molnupiravir
drug information
severe COVID-19
molnupiravir

---
Nous contacter.
24/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.